Programme by Day

For the most up-to-date Programme details as of press time, please click here.

Saturday, October 15
Sunday, October 16
Monday, October 17
Tuesday, October 18
Wednesday, October 19
Thursday, October 20

SATURDAY, OCTOBER 15
0800-1700	WUOF Conference
	SIU Board of Chairmen Meeting

SUNDAY, OCTOBER 16
0800-1200	WUOF Conference
	Sub-Specialty Society Symposia
0800-1215	Deutsche Gesellschaft für Urologie (DGU) (German Society of Urology)
	Chairs: Maurice Stephan Michel, Germany Bernd Wullich, Germany
	Introduction to the DGU
0800-0810	Structure and Boards of the DGU
	Stefan Müller, DGU President
	The Best of German Urology in 2011 in Clinical Practice and Research
	The Akademie der Deutschen Urologen (Academy of German Urologists)
0810-0830	Organization of Structured Urological Education in Germany
	Maurice Stephan Michel
	High-Ranked German Guidelines and Development of Excellence Centres
0830-0850	S-3 Guideline: Prostate Cancer
	Manfred P. Wirth
0850-0910	S-3 Guideline: Urinary Tract Infection
	Florian Wagenlehner
0910-0930	S-3 Guideline: Prophylaxis of Deep Vein Thrombosis
	Peter Walz
0930-0950	Certified Prostate Cancer Centres and Testicular Cancer Second Opinion Centre
	Axel Heidenreich
	Research in Urology
0950-1000	Structural Concepts of Research Promotion by the German Society of Urology
	Bernd Wullich
	Highest-Ranking Urological Research in Germany
	DGU Award Recepients Present Their Studies
1000-1020	Recipient of the Nitze Award 2011
	Jens Bedke
1020-1040	Recipient of the “Science Around Thirty” Award 2011
	Edwin Herrmann
1040-1050	Recipient of the AuF Award 2010 (I)
	Natalie Sampson
1050-1100	Recipient of the AuF Award 2010 (II)
	Friedemann Zengerling
	Top-Level Research by Network Concepts
1100-1115	Comprehensive Clinical and Molecular Characterization of Selective Renal Tumor Entities
	Kerstin Junker, on behalf of the German Network Renal Cell Tumors
1115-1130	The Relevance of National Communication Platforms for Realization of Multicenter Research Projects
	Peter Olbert, on behalf of the German Bladder Cancer Research Network
1130-1145	Training and Quality Control: Indispensable Tools for Outstanding Research
	Gerd Unteregger, on behalf of the German Prostate Cancer Consortium
1145-1200	Male Infertility Through Infectious and Inflammatory Diseases of the Urogenital Tract
	Florian Wagenlehner, on behalf of the Network for Urogenital Infection
1200-1215	Network for Infertility: Today and Tomorrow
	Wolfgang Weidner, on behalf of the Network for Infertility
0900-1200	International Society for Sexual Medicine (ISSM)
	Chair: John Dean, UK
0900-1000	Peyronie's Disease and Men's Sexual Well-Being
	Claudio Teloken, Brazil
1000-1100	The Impact of Chronic Diseases on Men's Sexual Health
	Ekaterina Kulchvenya, Russia
1100-1200	Assessment and Management of Low Sexual Desire in Men
	John Dean, UK
0900-1200	The Middle East Society for Organ Transplantation (MESOT) Symposium
	Chairs: Adib Rizvi, Pakistan Nasser Simforoosh, Iran
0900-0935	Technical Aspects of Kidney Transplantation: Experience with 3400 Cases
	Nasser Simforoosh, Iran
0935-1010	Transplantation Complications and Infections
	Adib Rizvi, Pakistan
1010-1045	Pediatric Kidney Transplantation
	Bassam Saeed, Syria
1045-1120	Transplantation in MESOT Countries
	Marwan Masri, Lebanon
1120-1155	Transplantation in Abnormal Lower Urinary Tract Patients
	Altaf Hashemi, Pakistan
	Pan-African Urological Surgeons Association (PAUSA)
	Chairs: Khaled Dabees, Egypt Serigne Gueye, Senegal
0900-0915	Introduction and Welcome
	Serigne Gueye, Programme Coordinator
	Mohamed Eissa, PAUS President
0915-0940	Management of Penile Curvature
	Hisham Badawi, Egypt
0940-1005	West African Lymphatic Filariasis Morbidity Management Project: History and Outcome
	Sunny D. Mante, Ghana
1005-1015	Questions and Answers
1015-1040	New Approaches to Prostate Cancer Management in the Native African
	E. Oluwabunmi Olapade-Olaopa, Nigeria
1040-1105	Metastatic Hormone Resistant Prostate Cancer: What Are the Options?
	Jean McDonald, UK
1105-1115	Questions and Answers
1115-1140	Robots, Laparoscopy and Lasers: Is High Tech Possible in Low-Resource Countries?
	Catherine deVries, USA
1140-1150	Questions and Answers
1150-1200	Conclusion: The Way Forward
	Khaled Dabees
	Serigne Gueye
	GURS Symposium
	Society of Genitourinary Reconstructive Surgeons

Treatment of Complications After the Treatment of Prostatic Disease “How I Do It”
Session 1: Urethral Stricture and Bladder Neck Contracture After TURP
Discussant: Ronald Kodama, Canada
0900-0925	Incidence, Causes, Endoscopic and Open Treatments
	Christopher Gonzalez, USA
0925-0930	Discussion and Questions
Session 2: Anastomotic Stricture After RRP
Discussant: Kurt McCammon, USA
0930-0955	Incidence, Causes, and Treatment (Radical Resection, Botox, Urolume and Open Repair)
	Richard Santucci, USA
0955-1000	Discussion and Questions
Session 3: Artificial Urinary Sphincter
Discussant: Frank Burks, USA
1000-1025	Primary and Secondary Applications of AUS
	Allen F. Morey, USA
1025-1030	Discussion and Questions
Session 4: Rectourethral Fistula
Discussant: Joel Gelman, USA
1030-1055	Transperineal Repair of Complex Rectourethral Fistulas
	Kenneth Angermeier, USA
1055-1100	Discussion and Questions
Session 5: The Devastated Outlet “I and II”
Discussants: Kurt McCammon, USA and Joel Gelman, USA
1100-1125	Complete Reconstruction vs Suprapubic Diversion (Outlet I)
	Margit Fisch, Germany
1125 -1150	Complete Reconstruction vs Suprapubic Diversion (Outlet II)
	Steven Brandes, USA
1150-1200	Discussion and Questions

1000-1200	SIU National Delegates' Meeting
1200-1300	Break
1300-1700	Sub-Specialty Symposia

1300-1600	European Association of Urology Symposium
	Chair
	Per-Anders Abrahamsson, Sweden
1300-1320	Screening for Prostate Cancer: An Update
	Fritz Schröder, Netherlands
1320-1340	Robotics in Surgery: A Real Advance?
	Walter Artibani, Italy
1340-1400	Optimal Treatment of High Risk Prostate Cancer
	Hein van Poppel, Belgium
1400-1420	What’s New in the Treatment of Castration-Resistant Prostate Cancer?
	Bertrand Tombal, Belgium
1420-1440	Break
1440-1500	Surgery for Stress Incontinence: Current Concepts and Future Directions
	Walter Artibani, Italy
1500-1520	What's New in Andrology?
	Wolfgang Weidner, Germany
1520-1540	Management of Small Renal Masses
	Didier Jacqmin, France
1540-1600	What Is the Role of Lasers in Management of Benign Prostate Disease?
	Rolf Muschter, Germany
1300-1700	European Society of Pediatric Urology
	Moderator: Rien Nijman, Netherlands
1300-1320	European Reflux Guidelines
	Rien Nijman
1320-1340	The Long-Term Results of Endoscopic Treatment of Reflux
	Göran Lackgren, Sweden
1340-1415	Debate: What Are My Indications for Endoscopic Treatment of Reflux?
	Moderator: Rien Nijman

1340-1345	Göran Läckgren, Sweden
1345-1350	Antoine Khoury, USA
1350-1355	Paolo Caione, Italy
1355-1400	Raimund Stein, Germany
1400-1415	Debate

1415-1445	Laparoscopy for Paediatric Renal Pathologies: An Update
	Alaa el Ghoneimi, France
1445-1500	Break
1500-1530	Current Management of PUV
	Raimund Stein, Germany
1530-1600	Update on the Management of Cryptorchidism
	Christian Radmayr, Austria
1600-1700	Panel on Distal Hypospadias
	Moderator: Barry Kogan, USA
	Panelists:
	Alaa el Ghoneimi
	Margit Fisch
	Marc David Leclair
	Emilio Merlini
1300-1700	Educational Course: International Continence Society (ICS) and Society for Urodynamics and Female Urology (SUFU)
	“Urogynecology Update”
	Chairs: Eric Rovner, USA; Werner Schaefer, USA
	Urodynamics and Biomechanics of Female Incontinence: Werner Schaefer
	Sonography in the Diagnoses of Pre- and Postoperative Bladder Dysfunction: Ralf Tunn, Germany
	SUI Surgery in 2011: Does One Operation Fit All? Eric Rovner, USA
	Current Concepts of Prolapse Surgery: Heinz Kölbl, Germany
	Mesh Complications in SUI/POP surgery: Sandip Vasavada, USA
	Evaluation of Patients with Neurogenic Bladder: Indications and Implications: Gary Lemack, USA
	Panel Discussion
1300-1600	Symposium on Urological Stents
	Chair: Daniel Yachia, Israel

1300-1310	Opening
	Daniel Yachia
1310-1340	Updates
	Identification of Conditioning Film Components on Indwelling Ureteral Stents and their Role in Bacterial Adhesion
	Dirk Lange, Canada
	Update in Metallic Stents in the Urinary Tract
	Ravi Kulkarni, UK
1340-1410	Biodegradable Materials in Urinary Tract Stenting:
	Biodegradable Urethral Stents: What Is New?
	Taina Isotalo, Finland
	Degradable Ureteral Stents
	Ben Chew, Canada
1410-1440	Panel on Post-Surgical Bladder Neck Stenosis
	Palliation or Definitive Surgery? Is There Another Approach?
	Gerald Jordan, USA
	TBC
	Allium RPS: Preliminary Experience
	Ofer Nativ, Israel
1440-1530	New and Upcoming Stent Designs for the Urinary Tract
	Stenting Blood Vessels or the Urinary Tract: What Makes It Different?
	Taina Isotalo
	A Novel 3.0F Ureteral Stent With Drainage Characteristics Of A 4.75 F JJ Stent
	Dirk Lange
	Is There a Need for New Materials or New Stent Designs in the Urinary Tract?
	Daniel Yachia
1530-1600	Break and Poster Viewing

	Poster Session A: Ask the Author
1600-1700	Poster Session B: Moderated Poster Session

1800-1900	Opening Ceremonies
	Plenary Hall, ICC Berlin
1900-2100	Welcome Reception
	Exhibit Hall, ICC Berlin

MONDAY, OCTOBER 17
0630-0745	Sponsored Symposia
0630-0800	Instructional Courses IC01 to IC04
	IC01: Transforming Urology in Africa: Designing Clinical and Research Collaborations
	Chair: Catherine deVries, USA
	Faculty:
	Catherine deVries, USA
	Serigne Gueye, Senegal
	Ira Sharlip, USA
	Stephen Watya, Uganda
	IC02: Management of Post-Prostatectomy Incontinence
	Chair: Ajay Singla, USA

0630-0635	Introduction
	Ajay Singla
0635-0650	Non-Surgical Management
	Stavros Charalampous, Greece
0650-0705	Adjustable Male Slings
	Rodrigo Leyton, Chile
0705-0720	Non-Adjustable Male Sling: AdVance
	Kurt McCammon, USA
0720-0735	Non-Adjustable Male Sling: InVance
	Ajay Singla
0735-0750	Artificial Urinary Sphincter: The Gold Standard
	Dirk De Ridder, Belgium
07500-0800	Round-Table Discussion and Conclusion
	Ajay Singla

Course description: The course is intended as an interactive session. In the first half all the presentations will be made while the second half will be structured as an interactive session with real case presentations and discussion of the possible treatment options. At the end, the participants should be able to recognize all the major complications of the artificial urinary sphincters procedures (AUS, Flowsecure, Urethral constrictor, ProACT), and all the sling procedures available worldwide. The treatment after a previous incontinence surgery will be discussed as well the management of very severe incontinence in multiply operated patients. Learning objectives: 1. To get familiar with the newer minimally invasive surgical options for the management of post-prostatectomy incontinence. 2. To learn how to manage a complicated patient with PPI 3. To learn the tricks of the trade and trouble-shoot for AUS in PPI 4. To learn the about the successes and complications associated with various surgical procedures for PPI.

	IC03: Prostate Cancer Diagnosis and Screening: New Methods to Approach an Old Problem
	Chair: Badrinath Konety, USA
0630-0635	Introduction
	Badrinath Konety
0635-0655	New Markers
	Badrinath Konety
0655-0715	New Biopsy and Other Diagnostic Techniques: Practical Pointers
	Stephen Jones, USA
0715-0735	Experience with ERSPC
	Monique Roobol, Netherlands
0735-0755	Meta-analysis and Evidence Synthesis on Prostate Cancer Screening
	Phil Dahm, USA
0755-0800	Conclusion
	Badrinath Konety
	IC04: Robotic-Radical Retropubic Prostatectomy
	Chair: Ashutosh Tewari, USA
0630-0635	Introduction and Welcome
	Ashutosh Tewari
0635-0700	Technical tips to Optimize Oncologic and Functional Outcomes
	Ashutosh Tewari
0700-0725	The Role of Pelvic Lymphadenectomy and How It Is Done in Robotic Prostatectomy
	Francesco Montorsi, Italy
0725-0750	Management of Complications and Improving Quality of Life After Robotic Prostatectomy
	Peter Wiklund, Sweden
0750-0800	Discussion and Concluding Remarks
	Ashutosh Tewari
Learning objectives: 1. How to enhance their surgical technique to improve outcomes for their patients 2. When and how to do a pelvic lymph node dissection robotically 3. How to manage complications after robotic prostatectomy and optimize quality of life for their patients 4. How robotic surgical results compare to open and laparoscopic outcomes

0745-1000	Plenary 1: Prostate Cancer
	Chairs: Gerald H. Jordan, USA Michael Marberger, Austria

0745-0755	Welcome Address
	Joachim Thüroff, SIU President
	Margit Fisch, Chair, Local Organizing Committee
	Gerald H. Jordan, Michael Marberger, Co-Chairs, SIU 2011 Scientific Programme
0755-0805	Pharmacology of Adrenoceptor Subtypes Creates New Drugs Treating LUTS/BPH and OAB
	Toichi Takenaka, Japan
0805-0810	Introduction to SIU-Astellas Lecture
0810-0830	SIU-Astellas Lecture
0830-0845	Don’t We Die from Prostate Cancer Any Longer?
	Peter Albertsen, USA
0845-0900	The Future of Screening for Prostate Cancer: An Optimistic View
	Fritz Schröder, Netherlands
0900-0920	EAU Lecture
	Manfred Wirth, Germany
0920-1000	Debate: Management of Low-Risk Localized Prostate Cancer
	Chair: Per-Anders Abrahamsson, Sweden
	Faculty:
	Active Surveillance - Laurence Klotz, Canada
	Radiotherapy - Thomas Wiegel, Germany
	Surgery - Peter Scardino, USA

1000-1200	Parallel Plenaries 1-3

	Parallel Plenary 1: Focal Therapy of Prostate Cancer
	Chairs: Peter Hammerer, Germany William Lynch, Australia
1000-1015	Does Clinical Unifocal PCA Translate into Prostatectomy pT2a Stage?
	Thomas Polascik, USA
1015-1030	Transrectal MRI Imaging
	Arnauld Villers, France
1030-1045	What Biopsy Strategy Does Focal Therapy Demand?
	Mark Emberton, UK
1045-1100	Robot Assisted Image Guided Focal Therapy of Prostate Cancer: Initial Results
	John Trachtenberg, Canada
1100-1115	MRI Thermometry During Ablation
	Laurence Klotz, Canada
1115-1130	Real Time Ultrasound Monitoring of Tissue Changes
	Michael Marberger, Austria
1130-1200	Focal Therapy of Low Risk Prostate Cancer Using MR Guided Focus Ultrasound: Initial Clinical Experience
	Christopher Cheng, Singapore
	Parallel Plenary 2: Pediatric Urology
	Chairs: Mohamed Eissa, Egypt Margit Fisch, Germany
1000-1015	Has Injection Therapy Changed Indications/Timing for Antireflux Surgery?
	Antoine E. Khoury, USA
1015-1030	Is There Still a Role for Long-Term Antibiotic Prophylaxis?
	Jean Hollowell, USA
1030-1045	Indications and Timing of Surgical Correction of UPJ Obstruction
	Barry Kogan, USA
1045-1125	Pro-Con Debate: Open vs. Laparoscopic vs. Robotic Surgery in Toddlers: Advantages and Limitations
	Open Surgery: Margit Fisch, Germany
	Laparoscopy: Marc David Leclair, France
	Robotic: Sarah Lambert, USA
1125-1140	Non-Neurogenic Voiding Disorders in Children
	Paolo Caione, Italy
1140-1155	Strategies for Treating Neurogenic Detrusor Overactivity in Myelomeningocele (MMC)
	Raimund Stein, Germany
	Parallel Plenary 3: Testis Cancer
	Chairs: Peter Albers, Germany Michael Jewett, Canada
1000-1030	Pro-Con Debate: The Contralateral Testis Should Always Be Biopsied
	Pro: Niels Skakkebaek, Denmark
	Con: Harry Herr, USA
1030-1110	Pro-Con Debate: Active Surveillance vs. Chemotherapy vs. RPLND in Stage I-IIa NGC TC
	Active Surveillance: Alan Horwich, UK
	Prophylactic Chemotherapy: Peter Albers, Germany
	Retroperitoneal Lymph Node Dissection: Paul Lange, USA
1110-1125	When Should You Do Retroperitoneal Dissection After Chemotherapy of Stage IIb-III NGCTC?
	Axel Heidenreich, Germany
1125-1140	Fertility and Testis Cancer
	JWA Ramsay, UK
1140-1155	Testis-Sparing Surgery
	Steve Riggs, USA

1200-1315	Break
	Sponsored Symposia Astellas Pharma Inc.
	Trust Me I'm a Doctor: Clinical Decisions in OAB
1200-1205	Chairman’s Introduction
	Eric Rovner, USA
1205-1225	Trust Me, I Know the Patient
	Elise De, USA
1225-1245	Trust Me, I Know the Latest Developments and Data
	Karl-Dietrich Sievert, Germany
1245-1305	Trust Me, I Know the Role of Guidelines
	Hidehiro Kakizaki, Japan
1305-1315	Discussion
	Summary and Close
	Eric Rovner, USA
	sanofi aventis
	Optimising Patient Care in mCRPC: Who, When and How to Treat
	Chair: John Fitzpatrick, Ireland
1200-1220	Changing Management Strategies in mCRPC
	John Fitzpatrick
1220-1305	Optimising Patient Care in mCRPC: A Case Study
	Amit Bahl, UK
	Nicolas Mottet, France
	John Fitzpatrick
•	Risk Stratification to Guide Multidisciplinary Team Treatment Decisions in mCRPC Nicolas Mottet
•	When and How to Use Chemotherapy in mCRPC Amit Bahl
1305-1310	Interactive Discussion
	All
1315-1445	Parallel Plenaries 4-5

	Parallel Plenary 4: Male Incontinence
	Chairs: Dirk De Ridder, Belgium Osamu Ogawa, Japan
1315-1330	Pathophysiology of Incontinence in Males
	Paul Abrams, UK
1330-1345	Physiotherapy and Electrical/Magnetic Stimulation—Do They Change Natural History of Post-Prostatectomy Incontinence?
	Christian Hampel, Germany
1345-1400	Do Drugs in Post-Prostatectomy Incontinence Do Any Good?
	Karl-Erik Andersson, USA
1400-1440	Panel Presentations and Discussion: Which Surgical Therapy for Which Patient?

1400-1410	Injectables and Balloons
	Christian Hampel, Germany
1410-1420	Slings, Slings, Slings
	Klaus Höfner, Germany
1420-1430	Hydraulic Controllable Sphincters
	Anthony Mundy, UK
1430-1440	Discussion

	Parallel Plenary 5: Potentially Lethal Infections
	Chairs: Mete Cek, Turkey Chris F. Heyns, South Africa
1315-1330	Fournier’s Gangrene
	Amir Zarrabi, South Africa
1330-1345	Emphysematous Pyelonephritis
	Dick Barnes, South Africa
1345-1400	Retroperitoneal Abscess
	Redouane Rabii, Morocco
1400-1430	Panel Discussion: Management of Multiply Resistant Infections in Urology Today

1400-1410	MRSA
	Daniel Shoskes, USA
1410-1420	ESBL
	Kurt Naber, Germany
1420-1430	Discussion

1430-1445	Male Circumcision for the Prevention of HIV
	Ira Sharlip, USA

1315-1445	Abstract Sessions
	Podium Session 1: Bladder Cancer
	Moderated Poster Session 1: Stones
	Moderated Poster Session 2: Adrenal, Kidney, Ureter: Benign & Malignant
	Moderated Poster Session 3: Prostate Cancer, Detection and Staging
	Video Session 1: Minimally Invasive Surgery I
	Video Session 2: BPO/LUTS and Oncology
1445-1515	Break
1515-1645	Surgical Tips Sessions 1-2
	Surgical Tips 1: Male Incontinence Surgery
	Chair: Christian Hampel, Germany
	Faculty:
	Dirk De Ridder, Belgium
	Vincent Delmas, France
	Wilhelm Hübner, Austria
	Surgical Tips 2: Robotic Surgery
	Chair: Ashutosh Tewari, USA
	Faculty:
	Vito Pansadoro, Italy
	Ashutosh Tewari, USA
	Joachim Thüroff, Germany
1515-1645	Abstract Sessions
	Podium Session 2: Prostate Cancer, Advanced
	Moderated Poster Session 4: Bladder Cancer
	Moderated Poster Session 5: BPO/LUTS: Intervention Therapy
	Moderated Poster Session 6: Renal Transplantation
	Moderated Poster Session 7: Infertility/Male Sexual Dysfunction
	Video Session 3: Trauma & Reconstruction
1645-1800	Sponsored Symposia
	Evaluating the Current Therapeutic Landscape for Advanced Prostate Cancer
	A prIME Oncology Symposium
	Chair: Cora Sternberg, Italy
1645-1650	Welcome and Introduction
	Cora Sternberg
1650-1705	Examining the Issues and Unmet Needs in the Treatment of Advanced Prostate Cancer
	Cora Sternberg
1705-1725	Integration of Newly Approved Therapies into the Continuum of Care for Advanced Prostate Cancer
	Thomas Powles, UK
1725-1745	What are the Promising Novel Strategies on the Horizon in Advanced Prostate Cancer?
	Karim Fizazi, France
1745-1800	Importance of the Multidisciplinary Team in Prostate Cancer: The Urologist’s Perspective
	Peter Mulders, Netherlands
1800	Concluding Remarks and Adjournment
	Cora Sternberg
	LUTS/BPH: The Clinical Advantages of the Novel Alpha Blocker Silodosin
	Recordati
1645-1650	Introduction
	Francesco Montorsi, Italy
1650-1705	Clinical Case 1
	Francesco Montorsi
1705-1720	Clinical Case 2
	Matthias Oelke, Germany
1720 -1730	Discussion and Conclusions
	Francesco Montorsi and Matthias Oelke
1900-2300	SIU Oktoberfest Night
	Berlin Station

TUESDAY, OCTOBER 18
0630-0745	Sponsored Symposia
	AMS
	Panel Discussion Male Urinary Incontinence
0630–0642	Introduction and Overview of Male Stress Urinary Incontinence
	Kurt McCammon, USA
0642–0655	Patient Selection for Anti-Incontinence Procedures
	Bill Lynch, Australia
0655–0710	AdVance and AdVance XP
	Ricarda Bauer, Germany
0710–0725	AUS Tips and Tricks
	Michael Metro, USA
0725–0745	Patient Presentations and Question and Answer
All Day	Live Surgery from Charité Hospital, Berlin
0630-0800	Instructional Courses IC05-IC09
	IC05: Robotic Partial Nephrectomy
	Chair: Craig Rogers, USA

0630-0655	Robotic Partial Nephrectomy
	Craig Rogers, USA
0655-0720	Robotic Nephroureterectomy and Upper Urinary Tract Reconstruction
	Ashok K. Hemal, USA
0720-0740	Establishing a Multiservice Surgical Robotic Program: Essential Elements of Clinical Safety and Financial Success
	Surena Matin, USA
0740-0800	Robotic Nephrectomy and Donor Nephrectomy
	Jacques Hubert, France
	IC06: Urethral Strictures: Three Ways to Solve Every Stricture (Penile, Panurethral, Bulbar, Traumatic)
	Chair: Miroslav Djordjevic, Serbia
0630-0700	Graft Urethroplasty: Is It Always Possible?
	Francisco Martins, Portugal
0700-0730	Flap Urethroplasty: Tricks and Traps!
	Miroslav Djordjevic
0730-0800	Anastomotic Urethroplasty: Challenges and Limits
	Allen Morey, USA

Course description: Urethral strictures play an important role in reconstructive urology. The importance of this problem is great, especially regarding all the potential complications not only in the functional, but also in the psychosocial and psychosexual aspects. All of these details make this field interesting-we are always in search of new and better solutions for the treatment of urethral strictures. The long-term follow up of these patients enables the best estimation of the achieved surgical results. Analysis of new surgical techniques, comparison of results with the results from different medical centers around the world, as well as the compilation of surveys related to overall patient satisfaction can lead to a conclusion which could point toward the improvement of the results in the treatment of this anomaly.

	IC07: Laparoscopic Donor Nephrectomy
	Chair: Alexander Bachmann, Switzerland
0630-0645	LESS and Donor Nephrectomy: Is There Still a Market?
	Andre Van der Merwe, South Africa
0645-0700	Laparoscopic Donor Nephrectomy: Better than Open?
	Serdar Deger, Germany
0700-0715	Cosmetic Aspects of Live Kidney Donors: Are They Really Important?
	Nicole Ebinger Mundorff, Germany
0715-0730	The Advantages of the Transperitoneal Route
	Nasser Simforoosh, Iran
0730-0745	Retroperitoneoscopic Donor Nephrectomy: Our Technique and Results
	Kazunari Tanabe, Japan
	IC08: Premature Ejaculation
	Chair: Ira Sharlip, USA
0630-0635	Introduction
	Ira Sharlip
0635-0655	Epidemiology of Premature Ejaculation
	Ira Sharlip
0655-0715	Genetics of Premature Ejaculation
	Marcel Waldinger, Netherlands
0715-0735	Oral Therapy of Premature Ejaculation
	Craig Donatucci, USA
0735-0755	Non-Oral Therapy of Premature Ejaculation
	Hossein Sadeghi, USA
0755-0800	Questions and Wrap-up
	All
	IC09: Focal Ablative Prostate Therapy
	Chair: John Ward, USA
0630-0635	Introductory Remarks
	John Ward
0635-0655	Prostate Biopsy for Patient Selection
	John Ward
0655-0700	Q&A
0700-0720	Prostate Cancer Imaging (MRI and Histoscanning)
	Mark Emberton, UK
0720-0725	Q&A
0725-0745	Targeted Prostate Cancer Ablation: Techniques and Outcomes
	Thomas Polascik, USA
0745-0750	Q&A
0750-0800	Panel Discussion with Audience and Closing Remarks

0745-1000	Plenary 2: Bladder Cancer
	Chairs: Patrick Coloby, France Joachim Thüroff, Germany

0745-0755	Clinical Pearls: The Past Year in Review: Oncology
	Vijay Sangar, UK
0755-0810	The 2004 WHO Classification of Urothelial Neoplasms Revisited
	Ruth Knüchel- Clarke, Germany
0810-0825	Re-TURB: Why, When and How?
	Harry Herr, USA
0825-0840	BCG for CIS: What Is Proven After 30 Years?
	Maurizio Brausi, Italy
0840-0925	High Grade pT1 BCA: How Early Cystectomy?
	Chair: Mark Soloway, USA
	Panelists:
	Hassan Abol-Enein, Egypt
	Richard Hautmann, Germany
	Wiking Månsson, Sweden
	Juan Palou, Spain
	Vito Pansadoro, Italy
0925-0940	Neoadjuvant Chemotherapy
	Cora Sternberg, Italy
0940-1000	Pro-Con Debate: Lymph Node Dissection Is Curative in Urological Cancers vs. Staging Only
	Chair: Arturo Mendoza Valdés, Mexico
	Curative: Urs E. Studer, Switzerland
	Staging Only: Joachim Thüroff, Germany

1000-1200	History Session: SIU meets Berlin – Urology a Century ago
	Chairs: Alain Jardin, France Dirk Schultheiss, Germany
	Cells, Microbes and Salvarsan
	Berlin: A Medical Metropolis in the Long 19th Century
	Thomas Schnalke, Germany
	History of the Early Years of the SIU
	Friedrich Moll, Germany
	James Israel (1848-1926): Founding Member of the SIU and Leading Kidney Surgeon of His Time
	Dirk Schultheiss, Germany
	Urology in Germany between 1933 and 1945
	Heiner Fangerau, Germany

1000-1200	Parallel Plenaries 6-8

	Parallel Plenary 6: Urinary Diversion
	Chairs: Hassan Abol-Enein, Egypt Richard Hautmann, Germany
1000-1020	CAU Lecture: Urinary Diversion: The Latin American Perspective Antonio Carlos Lima Pompeo, Brazil
1020-1100	Laparoscopic/Robotic vs. Open Urinary Diversion After Laparoscopic Cystectomy?
	Chair: Arnulf Stenzl, Germany
	Panelists:
	Hassan Abol-Enein, Egypt
	Octavio Castillo, Chile
	Richard Gaston, France
	Raj S. Pruthi, USA
	Michael Stöckle, Germany
	Peter Wiklund, Sweden
1100-1120	SIU-Albert Schweitzer Lecture
1120-1135	Is There Still a Role for Continent and Urinary Diversion?
	Urs E. Studer, Switzerland
1135-1150	The Long-Term Metabolic and Neoplastic Consequences of Urinary Diversion
	Randall Rowland, USA
	Parallel Plenary 7: Trauma From MIS
	Ingolf Tuerk, USA René Sotelo, Venezuela
1000-1015	Bleeding, Extravasation in Percutaneous Nephrolithotripsy
	Mahesh Desai, India
1015-1030	Ureteral Damage in Ureteroscopy
	Christoph Klinger, Germany
1030-1045	Bleeding, Bowel Injury, Conversion in Laparoscopic/Robotic Surgery
	Ingolf Tuerk, USA
1045-1055	Septic Complications
	Pilar Laguna, Netherlands
1055-1105	Urinary Extravasation
	Jens Rassweiler, Germany
1105-1115	The Forgotten Stent
	Gunter Janetschek, Austria
1115-1155	Round Table Discussion Based on Case Presentations: “Nihil Nocere”
	Chair: René Sotelo
	Panelists: All
	Parallel Plenary 8: Prostate Cancer
	Chairs: Christopher Cheng, Singapore Arnauld Villers, France
1000-1015	Quality of Life and Satisfaction with Therapy Amongst PCA Survivors
	Martin Sanda, USA
1015-1105	Panel Presentations and Discussion: Cost/Benefit Ratio of Chemoprevention
	Chair: Peter Albertsen, USA

1015-1025	Dietary Measures
	Hideyuki Akaza, Japan
1025-1035	Lifestyle Changes
	Arturo Mendoza Valdés, Mexico
1035-1045	Antioxidants/Anti-Inflammatory Agents
	Ahmad Shabsigh, USA
1045-1055	5a-Reductase Inhibitors
	Gerald Andriole, USA
1055-1105	Discussion

1105-1155	Panel Discussion Based on Case Presentations: Management of High-Risk Locally-Confined PCA
	Chair: Peter Scardino, USA
	Panelists:
	Arturo Mendoza Valdés, Mexico
	Michael Stöckle, Germany
	Hendrik Van Poppel, Belgium
	Thomas Wiegel, Germany

1200-1315	Break
	Sponsored Symposium Astellas Pharma Inc.
	The Male LUTS Debate
	Chair: Paul Abrams, UK
1200-1205	Introduction and Audience Polling
	Paul Abrams, UK
1205-1310	The motion: “a1-adrenoceptor Antagonist Monotherapy Is the Right
	First-Line Treatment for All Men with Bothersome LUTS”
	Presentations, panel debate, audience polling
	For the Motion
	François Desgrandchamps, France
	Mark Speakman, UK
	Against the motion
	Marcus Drake, UK
	Matthias Oelke, Germany
1310-1315	Take-Home Messages
	Paul Abrams, UK
	Supporter: Dendreon Corporation Sponsor: PIM & IMER
	International State of the Science of Immunotherapy in Prostate Cancer
	Chairs: Charles G. Drake, USA Adam S. Kibel, MD, USA
1200–1205	Activity Overview
	Charles G. Drake
1205–1225	International Comparison of the Changing Landscape of Advanced Prostate Cancer Management
	Kurt Miller, Germany
1225–1240	Optimal Incorporation of Immunotherapy in Early-Stage CRPC
	Charles G. Drake
1240–1255	Practical Application Case Series
	Adam S. Kibel, USA
1255–1315	Panel Discussion and Q&A
	Charles G. Drake
	Adam S. Kibel
	Noel W. Clarke, UK
	Kurt Miller
	Francesco Montorsi, Italy
	www.imeronline.com/779_prostate
1315-1645	New Findings/Recommendations from the 2011 International Consultation on Urologic Diseases (ICUD) on Prostate Cancer, Part I
	Chairs: Gerald Andriole, USA Manfred Wirth, Germany
1315-1335	A Brief History of Prostatic Diseases
	Peter Thompson, UK
1335-1355	Issues Related to Early Detection
	Monique Roobol, Netherlands
1355-1415	Advances in Biomarkers for Prostate Diseases
	Samir Taneja, USA
1415-1435	New Developments in the Anatomical and Metabolic Imagery of the Prostate and Metastatic Sites
	John Coleman, USA
1435-1455	Patients’ Perspectives on Prostate Diseases
	Paul Lange, USA
1455-1515	Metastatic PCA and Systemic Therapies
	Mario Eisenberger, USA
1515-1600	Questions/Answers/Case Discussions
	Parallel Plenary 9: Female Incontinence
	Chairs: E. Ann Gormley, USA Sender Herschorn, Canada

1315-1330	Urge or Stress: How Much Urodynamics is Necessary?
	Marcus Drake, UK
1330-1345	Severity of Incontinence Is Definition-Dependent: Results of a Prospective Randomized Study (TVT vs. Burch)
	Paul Hilton, UK
1345-1400	Pharmacotherapy of OAB
	Karl-Erik Andersson, USA
1400-1430	Pro-Con Debate: Vaginal Sacrospinous Fixation vs. Abdominal Sacrocolpopexy
	Chair: Eckhard Petri, Germany
	Vaginal Surgery: Heinz Kölbl, Germany
	Abdominal Surgery: Christian Hampel, Germany
1430-1445	Complications of Alloplastic Slings/Meshes
	Eckhard Petri, Germany
	Parallel Plenary 10: Urethral Reconstruction: Global Perspectives
	Chair: Sanjay Kulkarni, India

	Case Presentations
1315-1325	Sanjay Kulkarni, India
1325-1335	Reynaldo Gómez, Chile
1335-1345	Igor Vaz, Mozambique
1345-1355	Qiang Fu, China
1355-1405	Guido Barbagli, Italy
1405-1415	Daniela Andrich, UK
1415-1425	Allen Morey, USA
1425-1445	Discussion

1315-1445	Abstract Sessions
	Podium Session 3: Prostate Cancer, Advanced
	Moderated Poster Session 8: Infections
	Moderated Poster Session 9: BPO/LUTS
	Moderated Poster Session 10: Stones
	Moderated Poster Session 11: Pediatric Urology
	Video Session 4: Minimally Invasive Surgery II
	Video Session 5: Kidney & Ureteral Cancer
1445-1515	Break
1515-1645	Surgical Tips Sessions 3-4
	Surgical Tips 3: Female Incontinence Surgery
	Chair: Marcus Drake, UK
	Faculty:
	Heinz Kölbl, Germany
	Eckhard Petri, Germany
	Christian Hampel, Germany
	Surgical Tips 4: Hypospadias Repair
	Chair: Dragana Filipas, Germany
	Faculty:
	Raimund Stein, Germany
	Antoine E. Khoury, USA
	Paolo Caione, Italy
1515-1645	Abstract Sessions
	Podium Session 4: BPO/LUTS
	Podium Session 5: Bladder Cancer
	Podium Session 6: Minimally Invasive Surgery
	Moderated Poster Session 12: Trauma & Reconstruction
	Moderated Poster Session 13: Prostate Cancer, Localized
	Video Session 6: Stones
	Video Session 7: Prostate Cancer
1645-1800	Sponsored Symposia
	GSK sanofi pasteur
	Men with BPH in 2011: evidence to Support First Treatment Decisions
	Chair: Peter Hammerer, Germany
1645-1655	Welcome and Introduction
	Peter Hammerer, Germany
1655-1710	BPH Patients and Current Practice: Is There an Unmet Clinical Need?
	Peter Hammerer
1710-1730	What is the Role of Combination Therapy in First Treatment Decisions for BPH?
	J Curtis Nickel, Canada
1730-1745	How has BPH Treatment Changed with Recent Updates in Clinical Guidelines?
	Michael Marberger, Austria
1745-1755	Q&A Session
1755-1800	Summary and Conclusions
	Peter Hammerer
	Results and Implications of a Real-World Individual Patient Data
	Survey: Clinical Practice Gaps in Intermediate- and High-risk
	Non-Muscle Invasive Bladder Cancer (NMIBC) Management
	Chair: Mark Soloway, USA
1645–1655	Welcome & Introduction
	Mark Soloway
1655–1705	The Need for Bacillus Calmette-Guérin (BCG) for Optimizing Outcomes in NMIBC: Review of Current Literature
	Andreas Böhle, Germany
1705–1715	The Optimal Management of NMIBC: Review of Current Guidelines
	Joan Palou, Spain
1715–1735	Are we Practicing What we Preach? Overview and Key Findings from the International NMIBC Individual Patient Data Survey (IPDS)
	Fred Witjes, The Netherlands
1735–1750	Panel Discussion
	Assessing the Care Gap: Comparison of IPDS Results to Recommended Clinical Practice
1750–1800	Audience Discussion
	Closing the Care Gap: How to Improve the Management of NMIBC
1800	Summary and Close
	Mark Soloway
1830-2300	Optional Activities

WEDNESDAY, OCTOBER 19
0630-0745	Sponsored Symposia
0630-0800	Instructional Courses IC10-IC14

	IC10: Tips and tricks of Ileal Neobladder Construction with Nerve and Seminal Vesicle Sparing Cystectomy
	Chair: Richard Hautmann, Germany
0630-0650	Nerve-Sparing RCX
	Urs E. Studer, Switzerland
0650-0700	Seminal Vesical Sparing RCX
	Richard Hautmann
0700-0715	Orthoptopic Reconstruction of Both Sexes: Tricks of the Trade
	Urs E. Studer
0715-0730	Tips and Tricks of Ileal Neobladder Construction with Nerve and Seminal Vesicle Sparing Cystectomy
	Richard Hautmann
0730-0750	Potential Complications
	Björn G. Volkmer, Germany
0750-0800	Questions and Answers

Course description: Tips and Tricks of nerve sparing and seminal vesicle sparing radical cystectomy are presented by the most experienced hands in the world. The standards of orthotopic reconstruction of two pioneering institutions will be presented as well as the pitfalls and complications. Learning objective: Technique of nerve and seminal sparing RCX indication for RCX in 2011

	IC11: Management of Urothelial Carcinoma: Stage- and Site-Specific Discussions
	Chair: Wassim Kassouf, Canada
0630-0700	Practical Tips in the Management of Non-Muscle Invasive Bladder Cancer
	Ashish Kamat, USA
0700-0730	Optimizing Quality of Care for Muscle-Invasive Bladder Cancer
	Wassim Kassouf, Canada
0730-0800	Comprehensive Update on Upper Tract Urothelial Carcinoma
	Shahrokh Shariat, USA

Course description: Delineate key concepts in management of the entire spectrum of urothelial carcinoma (UC) and “tricks-of-the-trade” essential to the medical and surgical management of this disease. Emphasis will be placed on contemporary review of scientific literature and provide insight into the multi-disciplinary approach to UC. Learning objectives: 1. In management of non-muscle invasive bladder cancer, a risk-adapted approach will be reviewed, including a discussion on role of restaging TUR, first and second line intravesical chemotherapy and immunotherapy, BCG failure, etc. 2. In management of muscle invasive bladder cancer, we will discuss role of radical cystectomy, extent of lymphadenectomy, eligibility for continent diversions, neoadjuvant and adjuvant chemotherapy, bladder preservation strategies 3. In management of upper tract UC, we will discuss indications and outcome from endoscopic and percutaneous resection, nephroureterectomy, upper tract instillations, as well as role of perioperative chemotherapy

	IC12: Robotic Assisted Radical Cystectomy
	Chair: Juan Palou, Spain
0630-0650	RRC Surgical Technique in a Man With or Without Nerve Sparing Technique, and the Relation With Functional Results
	Juan Palou
0650-0710	RRC in Women With or Without Vaginal Resection
	Magnus Annerstedt, Sweden
0710-0730	Lymphadenectomy: Anatomical Landmarks and Basic Oncological Principles
	Ashok K. Hemal, USA
0730-0750	Urinary Diversion: Intra or Extracorporeal Diversion in RCC?
	Peter Wiklund, Sweden
0750-0800	Results of Open Cystectomy vs RRC (Complications, Bleeding)
	Juan Palou
	IC13: New Developments In Renal Stone Treatment Surgery
	Chair: Jean de la Rosette, Netherlands
0630-0700	Supine versus Prone PCNL
	Jean de la Rosette
0700-0730	Combined PCNL and URS
	Olivier Traxer, France
0730-0800	Drainage After PCNL: Percutaneous, Internal, None
	Glenn Preminger, USA

Course description: Recent studies have indicated a renaissance in renal stone treatment surgery during the last decade, which can be attributed to several factors. These include awareness of the limitations of shock wave lithotripsie with accumulating clinical experience of this approach. Moreover, improvements in the endourological procedure, which continue, have led to reductions in morbidity and yielded stone-free rates over 90 percent in treated patients. Several key factors have been identified that impact treatment outcomes and complication rates with PCNL, including indications for treatment, renal access, and available equipment. With the introduction of the latest generation flexible ureteroscopes, retrograde intrarenal surgery has been highly facilitated. Learning objectives: 1. Tailoring renal access in PCNL to the specific physical conditions 2. Indication and outcome of renal stone treatment with PCNL and Retrograde Intrarenal surgery. 3. Postoperative care addressing the type and need of drainage

	IC14: Prostatitis, Chronic Pelvic Pain Syndrome and Male Adnexitis
	Chairs: J. Curtis Nickel, Canada
	T. E. Bjerklund Johansen, Denmark
0630-0700	Bacterial Prostatitis: Diagnosis and Therapy
	Florian Wagenlehner, Germany
0700-0730	Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Clinical Evidence Revisited Provides Rationale for Therapeutic Strategy
	J. Curtis Nickel
0730-0800	Andrological Implications in Chronic Adnexitis
	Wolfgang Weidner, Germany

0800-1000	Plenary 3: Benign Prostatic Hyperplasia
	Chairs: Paul Abrams, UK Mostafa Elhilali, Canada

0800-0810	Clinical Pearls: The Past Year in Review: Lower Urinary Tract Dysfunction
	Frank Lee, UK
0810-0825	LUTS Suggestive of BPO: Is a Pressure-Flow Study Always Needed?
	Paul Abrams, UK
0825-0840	BPH and OAB
	Luc Valiquette, Canada
0840-0900	AUA Lecture: Medical Therapy for Male LUTS and BPH: An Update in 2011
	Claus Roehrborn, USA
0900-0915	Strategies in Medical Therapy of BPH: Combinations for BPE, BOO, OAB? How Long?
	John M. Fitzpatrick, Ireland
0915-0945	Pro-Con Debate: Is TURP Still the Gold Standard of Surgical Therapy?
	Chair: Mostafa Elhilali, Canada
	Con: Oliver Reich, Germany
	Pro: Michael Marberger, Austria

1000-1200	Parallel Plenaries 11-13

	Parallel Plenary 11: Stones
	Chair: Petrisor Geavlete, Romania Yinghao Sun, China
1000-1030	Panel Discussion Based on Case Presentations: Management of Staghorn Stones Today
	Chair: Mahesh Desai, India
	Panelists:
	Tarik Esen, Turkey
	Petrisor Geavlete, Romania
	Adrian Joyce, UK
	Nasser Simforoosh, Iran
1030-1045	Retrograde Intrarenal Stone Surgery
	Anup Patel, UK
1045-1100	Combined Percutaneous and Retrograde Ureteroscopic Approach
	Roberto M. Scarpa, Italy
1100-1115	Laparoscopic Stone Removal
	René Sotelo, Venezuela
1115-1145	Pro-Con Debate: ESWL vs. URS for Ureteral Stones
	Chair: Jorge Gutierrez-Aceves, Mexico
	ESWL: David Tolley, UK
	URS: Andreas Gross, Germany
1145-1200	Where is the Place for Medical Stone Therapy (Prevention, Chemolysis)?
	Glenn Preminger, USA
	Parallel Plenary 12: Kidney Cancer
	Chairs: Jan Breza, Slovakia Simon Tanguay, Canada
1000-1015	Active Surveillance: In Whom, Outcomes and Risks
	Michael Jewett, Canada
1015-1030	Energy Ablative Therapy: In Whom, Which Access?
	Michael Marberger, Austria
1030-1045	Robotic Tumor Resection: New Standard for Open Surgeons?
	Joachim Thüroff, Germany
1045-1100	Management of RCC with IVC Thrombus
	Markus Hohenfellner, Germany
1100-1115	Metastatic RCC: TKIs, mTOR -- Inhibitors or Antibodies?
	Samir Taneja, USA
1115-1200	Panel Discussion Based on Case Presentations: Which Treatment for Which Patient?
	Chair: Hein van Poppel, Belgium
	Panelists: All
	Parallel Plenary 13: Diagnosis of Urothelial Tumors
	Chairs: Imre Romics, Hungary Fred Witjes, Netherlands
1000-1015	Urinary Markers
	Yves Fradet, Canada
1015-1030	Fluorescence Cystoscopy
	Marek Babjuk, Czech Republic
1030-1045	Optical Coherence Tomography
	Seth Lerner, USA
1045-1100	Narrow Band Imaging
	Jean de la Rosette, Netherlands
1100-1115	Confocal Laser Endomicroscopy
	Wolfgang Jäger, Germany
1115-1155	Panel Discussion: Clinical Potential and Cost/Benefit Analysis
	Chair: Fred Witjes
	Panelists: All

1200-1315	Break
	Sponsored Symposia
1315-1445	Parallel Plenaries 14-16

	Parallel Plenary 14: Neuro-Urology
	Chairs: Francisco Cruz, Portugal Reynaldo Gómez, Chile
1315-1335	Pro-Con Debate: How to Detect the “Aggressive Detrusor”

1315-1325	Leak Point Pressure
	Sophie Fletcher, USA
1325-1335	Video Urodynamics
	Juergen Pannek, Switzerland

1335-1350	Posterior Rhizotomy +/- Electrical Stimulation
	Helmut Madersbacher, Austria
1350-1405	Botox Detrusor Injections
	Kurt McCammon, USA
1405-1420	Bladder Augmentation +/- Sphincteric Augmentation
	Anthony Mundy, UK
1420-1445	Case Presentations and Discussion
	Parallel Plenary 15: LESS Invasive Surgery
	Chairs: Claude Abbou, France Octavio Castillo, Chile
1315-1330	LESS
	Mihir Desai, USA
1330-1345	SMART
	Jens Rassweiler, Germany
1345-1400	NOTES
	Rene Sotelo, Venezuela
1400-1415	MIES
	Pradeep Rao, India
1415-1445	Panel Discussion: Translating the Plethora of Acronyms into Clinical Reality
	Chair: Gunter Janetschek, Austria
	Panelists: All
	Parallel Plenary 16: Urogenital Fistula
	Chairs: Suzy Elneil, UK Serigne Gueye, Senegal
1315-1330	Evaluation and Classification of VVF
	Oumarou Sanda Ganda, Niger
1330-1355	Surgical Principles and Early Management of VVF
	Kees Waaldijk, Nigeria
1355-1410	Iatrogenic Genito-Urinary Fistula: Clinical Features and Management
	Dirk De Ridder, Belgium
1410-1425	Global Perspectives on Fistula Care and Training
	Serigne Gueye
1425-1445	Discussion

1315-1445	Abstract Sessions
	Podium Session 7: Prostate Cancer, Localized
	Moderated Poster Session 14: Minimally Invasive Surgery
	Moderated Poster Session 15: Penile/Testis: Benign & Malignant
	Moderated Poster Session 16: Prostate Cancer: Staging, Advanced & Markers
	Video Session 8: Miscellaneous
	Video Session 9: Adrenal, Kidney & Miscellaneous
1445-1500	Break
1500-1630	General Assembly
1630-1745	Sponsored Symposia
1930-2300	SIU Gala Banquet
	The Schlüterhof, German Historic Museum

THURSDAY, OCTOBER 20
0800-1200	Main Plenary 4
	Chairs: Mahesh Desai, India Luc Valiquette, Canada

0800-0810	Clinical Pearls: The Past Year in Review: Stones/Endourology
	Matthew Bultitude, UK
0810-0830	PAUSA Lecture: Bladder Carcinoma in Africa: Epidemiology and Treatment
	Ismail Khalaf, Egypt
0830-0850	Evidence-Based Medicine In Its Use in Everyday Practice
	John M. Fitzpatrick, Ireland
0850-0905	Meeting the Challenges of Evidence-Based Prostate Cancer: Early Detection and Treatment
	Peter Carroll, USA
0905-1110	New Findings/Recommendations from the 2011 International Consultation on Urologic Diseases (ICUD) on Prostate Cancer, Part II
	Chairs: Gerald Andriole, USA; Manfred Wirth, Germany

0905-0920	Prevention
	Tim Wilt, USA
0920-0940	Epidemiology and Natural History of Prostate Cancer
	Seth Strope, USA
0940-0955	Biomarker Identification of Active Surveillance Candidates
	Jack Schalken, Netherlands
0955-1010	Low-Risk Localized PCA
	Peter Carroll, USA
1010-1025	High-Risk Localized PCA
	William Aronson, USA
1025-1050	Questions and Discussion
1050-1110	Special Lecture “Cost of Prostate Cancer Healthcare”
	Stephen Riggs, USA

1110-1130	UAA Lecture: Holmium Laser Enucleation of the Prostate (HoLEP): Evolution of a Surgical Technique
	Peter Gilling, New Zealand
1130-1135	Farewell
	Joachim Thüroff, Germany
1135-1145	Invitation to SIU 2012 in Fukuoka
	Mahesh Desai, India
	Seiji Naito, Japan